ACLS

Business Context and Reporting Period

Company: Axcelis Technologies, Inc.
Filing Type: Form 10-K (Annual Report)
Period Ended: December 31, 2002
Industry: Semiconductor Capital Equipment (Ion Implantation, Dry Strip, Photostabilization, Thermal Processing)

Axcelis is a worldwide producer of semiconductor fabrication equipment. The company operates as a single business segment and maintains a 50-50 joint venture in Japan with Sumitomo Heavy Industries, Ltd. (SEN). The 2002 fiscal year was characterized by a continued downturn in the semiconductor industry, resulting in reduced capital spending by customers.

Key Financial Metrics (Fiscal Year 2002)

Material Changes vs. Prior Period

• Revenue Decline: Net sales decreased 15.2% to $309.7 million, driven by lower capital investment in the semiconductor industry. Ion implantation sales dropped 20.2%, while other products (dry strip, photostabilization, thermal) increased 4.8%.
• Margin Compression: Gross margin declined to 33.6% from 35.9% due to lower manufacturing capacity utilization and a higher mix of 300mm sales, which currently carry lower average margins.
• Operating Expenses: General and administrative expenses decreased 22.9% primarily due to reduced litigation costs related to the patent dispute with Applied Materials, Inc. Research and development expenses decreased 5.8% as the company completed the launch of its 300mm products.
• Debt Issuance: In January 2002, the company issued $125 million in 4.25% Convertible Subordinated Notes, resulting in $5.8 million of interest expense for the year.
• Accounting Changes: The company adopted SFAS No. 142, eliminating the amortization of goodwill. This reduced amortization expense by $7.8 million compared to 2001.

Guidance, Outlook, and Risks

Outlook: Management expects Q1 2003 revenues to range between $75 million and $85 million, an increase from Q4 2002 revenues of $65 million. Gross margins are projected at approximately 30%, with a net loss per share expected between $0.06 and $0.08.

Management Commentary: The company is actively managing its cost structure to improve profitability while maintaining resources for a potential industry upturn. The transition to 300mm wafers is expected to drive future demand, though current margins on these tools are lower.

Risks and Contingencies:

• Legal Proceedings: Axcelis is engaged in patent infringement litigation against Applied Materials, Inc. regarding medium current/high energy ion implanters. While management believes the claims are meritorious, the outcome is uncertain.
• Customer Concentration: The top 10 customers accounted for 63.5% of net sales in 2002. IBM alone represented 14.2% of sales.
• Joint Venture Dependence: Access to the Japanese market relies on the SEN joint venture. Royalty income from SEN was $8.2 million in 2002.
• Deferred Tax Assets: The company holds $73.7 million in deferred tax assets. If future taxable income projections are not met, a valuation allowance could be required, resulting in a non-cash charge to earnings.

Investor Verification Checklist

• Debt Covenants: Verify compliance with the financial covenants of the $125 million Convertible Notes and the $50 million Revolving Credit Facility.
• 300mm Margin Trajectory: Monitor the gross margin mix as the percentage of 300mm sales increases, as these currently dilute overall margins.
• Legal Litigation Status: Track the progress of the patent lawsuit against Applied Materials, Inc., as a loss could impact competitive positioning and result in damages.
• Deferred Tax Realization: Assess the company's ability to generate sufficient taxable income to utilize the $73.7 million in deferred tax assets within the next three years.
• Backlog Conversion: Evaluate the conversion rate of the $60 million backlog into revenue, noting that orders are subject to cancellation or rescheduling.